首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1489250

全球伴侶動物藥品市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Companion Animal Pharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球伴侶動物藥品市場需求預計將從 2023 年的 206.9 億美元達到 2032 年近 322.6 億美元的市場規模，2024-2032 年研究期間複合年成長率為 5.06%。

伴侶動物藥品是專門為狗、貓和其他家畜等寵物開發的藥物和治療方法。這些藥物可解決各種健康問題，包括感染、慢性病、疼痛管理和預防保健。產品可包括抗生素、疫苗、抗發炎藥物以及關節炎、心絲蟲和跳蚤感染的治療藥物。這些藥物的開發和監管確保它們對動物應用安全有效，有助於維持寵物的健康和福祉，寵物通常被認為是家庭的重要成員。

市場動態

由於全球寵物飼養量的增加以及人類與動物之間聯繫的日益加深，伴侶動物藥品市場正在經歷成長。隨著越來越多的人將寵物視為家庭成員，他們更願意為寵物的健康和福祉花錢。關節炎、糖尿病和心血管疾病等伴侶動物慢性疾病的增加增加了對有效藥物治療的需求。此外，獸醫學的進步導致了針對伴侶動物的新的和改進的藥物的開發，提高了它們的生活品質和壽命。寵物主人對預防性醫療措施和先進治療方案的認知不斷增強，這進一步推動了市場的發展。

此外，獸醫診所和醫院的擴張以及獸醫專業人員數量的增加支持了伴侶動物藥品的成長。對動物保健產品的監管批准和支持也在推動市場成長方面發揮著不可或缺的作用。此外，寵物保險的採用使得寵物主人能夠負擔昂貴的治療費用，從而增加了對伴侶動物藥品的需求。然而，高昂的開發成本和嚴格的監管要求可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球伴侶動物藥品市場的每個細分市場進行了包容性評估。伴侶動物製藥產業的成長和趨勢為本研究提供了整體方法。

市場區隔

伴侶動物藥品市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按形式

馬匹
貓
小狗
伴侶動物

按指示

皮膚科疾病
傳染性疾病
行為疾病
骨科疾病

按配銷通路

醫院藥房
電子商務
零售

按產品分類

疫苗
生物製劑

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲伴侶動物藥品市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。伴侶動物藥品市場的主要參與者包括默克動物保健公司、碩騰公司、Dechra Pharmaceuticals PLC、Elanco動物保健公司、Neogen Corporation、勃林格殷格翰動物保健公司、Aratana Therapeutics、拜耳動物保健公司、Norbrook Laboratories、 Virbac、Kindred Biosciences、Ceva聖動物。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按形式分類的市場吸引力分析
- 按指標進行的市場吸引力分析
- 按配銷通路分類的市場吸引力分析
- 按產品分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球伴侶動物藥品市場分析：依形式

表格概覽
歷史和預測資料分析形式
馬匹
貓
小狗
伴侶動物

第 6 章：全球伴侶動物藥品市場分析：依適應症分類

按指示概述
按指示進行歷史和預測資料分析
皮膚科疾病
傳染性疾病
行為疾病
骨科疾病

第 7 章：全球伴侶動物藥品市場分析：按分銷管道

配銷通路概述
按配銷通路進行歷史和預測資料分析
醫院藥房
電子商務
零售

第 8 章：全球伴侶動物藥品市場分析：依產品

概述（按產品）
按產品分類的歷史和預測資料分析
疫苗
生物製劑

第 9 章：全球伴侶動物藥品市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：伴侶動物製藥公司的競爭格局

伴侶動物藥品市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Merck Animal Health

公司簡介
公司收入
產品
最近的發展

Zoetis Inc.

公司簡介
公司收入
產品
最近的發展

Dechra Pharmaceuticals PLC

公司簡介
公司收入
產品
最近的發展

Elanco Animal Health

公司簡介
公司收入
產品
最近的發展

Neogen Corporation

公司簡介
公司收入
產品
最近的發展

Boehringer Ingelheim Animal Health

公司簡介
公司收入
產品
最近的發展

Aratana Therapeutics

公司簡介
公司收入
產品
最近的發展

Bayer Animal Health

公司簡介
公司收入
產品
最近的發展

Norbrook Laboratories

公司簡介
公司收入
產品
最近的發展

Virbac

公司簡介
公司收入
產品
最近的發展

Kindred Biosciences

公司簡介
公司收入
產品
最近的發展

Ceva Sante Animale

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114742

The global demand for Companion Animal Pharmaceuticals Market is presumed to reach the market size of nearly USD 32.26 Billion by 2032 from USD 20.69 Billion in 2023 with a CAGR of 5.06% under the study period 2024-2032.

Companion animal pharmaceuticals are medications and treatments specifically developed for pets like dogs, cats, and other domestic animals. These pharmaceuticals address various health issues, including infections, chronic conditions, pain management, and preventive care. Products can include antibiotics, vaccines, anti-inflammatory drugs, and treatments for arthritis, heartworm, and flea infestations. The development and regulation of these medications ensure they are safe and effective for animal application, contributing to maintaining the health and well-being of pets, which are often considered important members of their families.

MARKET DYNAMICS

The companion animal pharmaceuticals market is experiencing growth due to the increasing pet ownership worldwide, coupled with a growing human-animal bond. As more people consider pets family members, they are more willing to spend on their health and well-being. The rise in chronic diseases among companion animals, such as arthritis, diabetes, and cardiovascular conditions, has increased the demand for effective pharmaceutical treatments. Additionally, advancements in veterinary medicine have resulted in the development of new and improved pharmaceuticals for companion animals, enhancing their quality of life and longevity. The growing awareness among pet owners about preventive healthcare measures and the availability of advanced treatment options is further boosting the market.

Furthermore, the expansion of veterinary clinics and hospitals and the increasing number of veterinary professionals support the growth of companion animal pharmaceuticals. Regulatory approvals and support for animal healthcare products also play an integral role in driving market growth. Moreover, pet insurance adoption has made expensive treatments more affordable for pet owners, increasing the demand for companion animal pharmaceuticals. However, high development costs and stringent regulatory requirements may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Companion Animal Pharmaceuticals. The growth and trends of Companion Animal Pharmaceuticals industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Companion Animal Pharmaceuticals market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Form

Horses
Cats
Dogs
Companion Animals

By Indication

Dermatologic Diseases
Infectious Diseases
Behavioral Diseases
Orthopedic Diseases

By Distribution Channel

Hospital Pharmacy
E-Commerce
Retail

By Product

Vaccine
Biologics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Companion Animal Pharmaceuticals market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Companion Animal Pharmaceuticals market include Merck Animal Health, Zoetis Inc., Dechra Pharmaceuticals PLC, Elanco Animal Health, Neogen Corporation, Boehringer Ingelheim Animal Health, Aratana Therapeutics, Bayer Animal Health, Norbrook Laboratories, Virbac, Kindred Biosciences, Ceva Sante Animale. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. COMPANION ANIMAL PHARMACEUTICALS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Form
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Product
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY FORM

5.1. Overview By Form
5.2. Historical and Forecast Data Analysis By Form
5.3. Horses Historic and Forecast Sales By Regions
5.4. Cats Historic and Forecast Sales By Regions
5.5. Dogs Historic and Forecast Sales By Regions
5.6. Companion Animals Historic and Forecast Sales By Regions

6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY INDICATION

6.1. Overview By Indication
6.2. Historical and Forecast Data Analysis By Indication
6.3. Dermatologic Diseases Historic and Forecast Sales By Regions
6.4. Infectious Diseases Historic and Forecast Sales By Regions
6.5. Behavioral Diseases Historic and Forecast Sales By Regions
6.6. Orthopedic Diseases Historic and Forecast Sales By Regions

7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1. Overview By Distribution Channel
7.2. Historical and Forecast Data Analysis By Distribution Channel
7.3. Hospital Pharmacy Historic and Forecast Sales By Regions
7.4. E-Commerce Historic and Forecast Sales By Regions
7.5. Retail Historic and Forecast Sales By Regions

8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY PRODUCT

8.1. Overview By Product
8.2. Historical and Forecast Data Analysis By Product
8.3. Vaccine Historic and Forecast Sales By Regions
8.4. Biologics Historic and Forecast Sales By Regions

9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE COMPANION ANIMAL PHARMACEUTICALS COMPANIES

10.1. Companion Animal Pharmaceuticals Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF COMPANION ANIMAL PHARMACEUTICALS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Merck Animal Health
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Zoetis Inc.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Dechra Pharmaceuticals PLC
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Elanco Animal Health
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Neogen Corporation
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Boehringer Ingelheim Animal Health
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Aratana Therapeutics
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Bayer Animal Health
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Norbrook Laboratories
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Virbac
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Kindred Biosciences
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Ceva Sante Animale
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments